Feed HAE
HA

Haemonetics

HAE · NYSE

$107.02 +0.19% (+$0.20)
1M -1.38%
Market Cap $4.94B
P/E Ratio 51.31x
Div. Yield -
ROE 11.35%

Bulios Fair Price

$63.78

40.4% downside

Trenutna cena

$107.02

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica HAE trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Strong
8/9
Valuation
41 /100
Fair
EV/EBITDA 22.55x
P/S 3.65x
P/B 5.90x
Growth
84 /100
Growing
Rev. growth 11.07%
FCF growth 23.43%
Book val. growth 3.08%
Profitability
83 /100
Strong
Net margin 7.12%
Op. margin 18.18%
FCF margin 21.54%
Quality
48 /100
Average
ROE 11.35%
ROA 4.07%
Asset turnover 0.57x
Debt
48 /100
Moderate
Current ratio 3.08x
Int. coverage 4.94x
Net debt/EBITDA 3.64x
Stability
67 /100
Stable
Rev. volatility 6.89%
EPS volatility 85.38%
Profitable years 6

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o HAE
Online

O podjetju

Haemonetics Corporation is an American company specializing in the development and manufacturing of medical technologies focused on blood product processing. Founded in 1971, the company’s primary focus is on innovations in blood transfusion, blood component separation, and patient monitoring. Haemonetics provides products and solutions for hospitals, blood banks, and transfusion centers that help optimize the processes of blood donation and usage, while ensuring safety and treatment efficiency. The company is known for its advanced devices and systems for separating plasma, red blood cells, and platelets, ensuring precision and quality in handling blood products.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Christopher A. Simon

Employees

3,009

Headquarters

Boston

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

42d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.